Lyophilisation Explained
Lyophilisation, or freeze-drying, removes water from a frozen material under reduced pressure. It can improve the practical stability of some peptide materials, but it does not guarantee purity, sterility or indefinite shelf life.
- Published
- 20 July 2026
- Last reviewed
- 20 July 2026
- Reading time
- 8 minutes
- Author
- PurePeps Editorial Team
What is lyophilisation?
Lyophilisation is commonly called freeze-drying.
In a typical process, a solution is:
- frozen;
- exposed to reduced pressure;
- dried by sublimation;
- subjected to further drying to reduce remaining bound or adsorbed water.
Sublimation is the direct transition of ice into water vapour without first becoming liquid water.
The process is usually divided into:
- freezing;
- primary drying;
- secondary drying.
Freezing
During freezing, water forms ice and the remaining dissolved components become concentrated in the unfrozen phase.
Freezing conditions can affect:
- ice-crystal size;
- pore structure;
- drying behaviour;
- concentration gradients;
- physical form;
- product appearance.
The material's composition influences how it behaves during freezing.
Primary drying
During primary drying, chamber pressure is reduced and heat is carefully supplied.
Ice sublimes through the dried layer and leaves the product as vapour.
Important parameters can include:
- shelf temperature;
- chamber pressure;
- product temperature;
- condenser performance;
- duration;
- equipment loading.
Excessive product temperature can damage the physical structure of the dried material.
Secondary drying
Primary drying removes most frozen water, but some water remains associated with the material.
Secondary drying uses controlled temperature and low pressure to remove additional adsorbed or bound water.
The finished material normally retains some residual moisture. Lyophilisation does not mean that every water molecule has been removed.
Why lyophilisation is used
For some materials, converting a solution into a dry solid can reduce certain degradation pathways and make storage more practical.
Potential advantages may include:
- reduced molecular mobility;
- reduced hydrolytic degradation;
- improved storage stability;
- easier transport in some circumstances;
- rapid redissolution where a validated procedure exists.
These benefits depend on the formulation and process. Lyophilisation is not automatically beneficial for every peptide.
Process-related risks
Lyophilisation can also introduce stress.
Potential concerns include:
- freezing stress;
- concentration of solutes;
- pH shifts during freezing;
- oxidation;
- aggregation;
- incomplete drying;
- excessive residual moisture;
- over-drying;
- collapse or shrinkage;
- stopper or container problems;
- contamination during an inadequately controlled process.
The process therefore requires defined parameters and suitable finished-material testing.
Residual moisture
Residual moisture can affect:
- chemical stability;
- physical stability;
- powder flow;
- aggregation;
- glass-transition behaviour;
- long-term storage.
Water content may be measured using a suitable method such as Karl Fischer analysis, where appropriate.
A visually dry cake is not proof of an acceptable water-content result.
Cake appearance
A lyophilised material may appear as:
- a uniform cake;
- a loose powder;
- a shrunken cake;
- a fragmented cake;
- material attached to the vial wall.
Appearance can provide useful manufacturing information, but it cannot establish identity, purity, content or stability by itself.
A visually attractive cake can still fail an analytical specification.
Container closure
The vial and stopper help protect the material from:
- atmospheric moisture;
- oxygen;
- contamination;
- physical damage;
- loss of vacuum or inert atmosphere where applicable.
Container-closure integrity and storage conditions therefore remain important after drying.
Lyophilised does not mean sterile
Freeze-drying is not, by itself, a sterilisation process.
A sterile lyophilised material requires an appropriate sterile-manufacturing strategy, contamination control and supporting testing.
A non-sterile material does not become sterile merely because water has been removed.
Lyophilised does not mean indefinitely stable
Shelf life and retest periods require stability evidence.
Factors affecting stability may include:
- peptide sequence;
- chemical form;
- formulation;
- residual moisture;
- oxygen exposure;
- light;
- temperature;
- packaging;
- shipping excursions.
Generic statements should not replace product- and batch-specific information.
- Lyophilisation consists of freezing, primary drying and secondary drying.
- Primary drying removes ice by sublimation.
- Secondary drying reduces remaining associated water.
- Residual moisture normally remains and may require measurement.
- Cake appearance is not proof of analytical quality.
- Freeze-drying is not a sterilisation process.
- Stability claims require supporting data.
FAQs
- Is lyophilisation the same as ordinary evaporation?
- No. The main water-removal stage occurs through sublimation from a frozen state under reduced pressure.
- Does lyophilised material contain no water?
- Not necessarily. Some residual moisture generally remains.
- Is every lyophilised peptide more stable than a solution?
- Not automatically. Stability depends on the individual peptide, formulation, process and storage conditions.
- Does a well-formed cake prove high purity?
- No. Visual appearance does not establish identity, purity or content.
- Does freeze-drying sterilise a product?
- No. Lyophilisation is not itself a sterilisation method.
References
- 1.US Food and Drug Administration. “Lyophilization of Parenteral Products.”Source type: Regulatory guidance · Accessed 20 July 2026View source (opens in a new tab)
- 2.European Medicines Agency. “Guideline on the Development and Manufacture of Synthetic Peptides.”Source type: Scientific guideline · Accessed 20 July 2026View source (opens in a new tab)
- 3.International Council for Harmonisation. “Q1A(R2): Stability Testing of New Drug Substances and Products.”Source type: Scientific guideline · Accessed 20 July 2026View source (opens in a new tab)
- 4.International Council for Harmonisation. “Q5C: Stability Testing of Biotechnological/Biological Products.”Source type: Scientific guideline · Accessed 20 July 2026View source (opens in a new tab)
Related research
Information presented in the PurePeps Research Library is provided for general laboratory, analytical and scientific reference. It does not constitute medical advice, treatment guidance, legal advice or a recommendation for human or veterinary use.